A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519114-31-00

Acronym

CLN-978-RA-101

Enrollment

Registered

2025-04-11

Start date

2025-05-15

Completion date

Unknown

Last updated

2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment-Refractory Rheumatoid Arthritis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026